Titan Pharmaceuticals -3% on pricing of $9.7M direct offering

Jan. 15, 2021 9:43 AM ETTitan Pharmaceuticals, Inc. (TTNP)TTNPBy: Pranav Ghumatkar, SA News Editor
  • Titan Pharmaceuticals (TTNP -2.9%) enters into a securities purchase agreement to purchase ~$9.7M of its common stock and warrants in a registered direct offering.
  • The combined purchase price for one share of common stock and each warrant will be $3.55.
  • Under the terms, it has agreed to sell ~2.73M shares of its common stock and warrants to purchase up to an aggregate of ~2.73M shares of common stock.
  • Net proceeds from the registered direct offering and concurrent private placement to be ~$8.9M.
  • Closing date on or about Jan. 20, 2021.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.